Medicxi

Overview

Medicxi is a European life sciences investment firm that specializes in drug discovery and therapeutic development by creating, investing in, and supporting biotech companies across the full drug development continuum.

Year Founded

2016

Portfolio Companies

Website

medicxi.com

Investments

Medicxi investments
Company	Date	Stage	Lead
Vaderis Therapeutics	Aug 2026	Series B	Co-investor
Fore Biotherapeutics	Jul 2026	Series D-2 Extension	Lead
Ethyreal Bio	Jun 2026	Series B	Co-investor
Altesa BioSciences	Feb 2026	Series B	Co-investor
Ethyreal Bio	Jan 2026	Series B	Co-investor

View all investments

Key People

Giuseppe Zocco

Co-Founder And Partner

Benjamin Perry

Venture Partner

Charles Grummitt

Venture Partner

Marco Prunotto

Venture Partner

Stephen Rapecki

Venture Partner

Thibaut De Smedt

Venture Partner

Giovanni Mariggi

Partner

Giovanni Pericolini

Partner And CFO

Shyam M.

Principal

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

FAQ

Firmographic Details

HeadquartersLondon

Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?